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Binding of insulin receptor substrate proteins 1 and 2
(IRS1/2) to the insulin receptor (IR) is essential for the
regulation of insulin sensitivity and energy homeo-
stasis. However, the mechanism of IRS1/2 recruit-
ment to the IR remains elusive. Here, we identify
adaptor protein APPL1 as a critical molecule that
promotes IRS1/2-IR interaction. APPL1 forms a com-
plex with IRS1/2 under basal conditions, and this
complex is then recruited to the IR in response to
insulin or adiponectin stimulation. The interaction
between APPL1 and IR depends on insulin- or adipo-
nectin-stimulated APPL1 phosphorylation, which is
greatly reduced in insulin target tissues in obese
mice. appl1 deletion in mice consistently leads to
systemic insulin resistance and a significant reduc-
tion in insulin-stimulated IRS1/2, but not IR, tyrosine
phosphorylation, indicating that APPL1 sensitizes
insulin signaling by acting at a site downstream of
the IR. Our study uncovers a mechanism regulating
insulin signaling and crosstalk between the insulin
and adiponectin pathways.
INTRODUCTION
The adaptor protein APPL1 interacts with adiponectin receptors
and plays a critical role in mediating the insulin-sensitizing effect
of adiponectin in muscle (Mao et al., 2006) and endothelial cells
(Cheng et al., 2007). A number of studies also suggest that
APPL1 has a direct effect on insulin signaling in cells. Suppres-
sion of APPL1 by RNAi impaired insulin-stimulated Akt activationCand membrane translocation of GLUT4 in L6 myocytes and 3T3-
L1 adipocytes (Mao et al., 2006; Saito et al., 2007). In addition,
overexpression of APPL1 in mouse liver potentiates insulin-
mediated inhibition of hepatic glucose production and alleviates
diabetes, while suppressing APPL1 expression in mouse liver
leads to glucose intolerance (Cheng et al., 2009). However, the
underlying mechanisms remain unclear.
APPL1 contains multiple function domains, including the Bin1/
amphiphysin/rvs167 (BAR) domain, the pleckstrin homology
(PH) domain, the phosphotyrosine binding (PTB) domain, and
the CC motif (Deepa and Dong, 2009). Accumulating data
suggest that APPL1 could function as a platform orchestrating
multiple signaling pathways (Deepa and Dong, 2009). Acting as
an anchoring protein, APPL1 facilitates LKB1 translocation
from the nucleus to the cytosol, where it phosphorylates AMP-
activated protein kinase (AMPK) in response to adiponectin
stimulation (Fang et al., 2010; Zhou et al., 2009). APPL1 also
mediates adiponectin-stimulated p38 mitogen-activated protein
kinase (MAPK) activation by scaffolding the TAK1/MKK3/p38
MAPK cascade (Xin et al., 2011). By interacting with TRB3, an
endogenous Akt inhibitor, APPL1 has been shown to enhance
insulin-stimulated Akt activity (Cheng et al., 2009; Mitsuuchi
et al., 1999; Saito et al., 2007; Yang et al., 2003).
In the current study, we show that knockout (KO) of APPL1 in
mice reduced insulin and adiponectin signaling and led to
systemic insulin resistance. We found that APPL1 interacts
with insulin receptor substrate proteins 1 and 2 (IRS1/2) and
promotes IRS1/2 proteins to interact with the insulin receptor
(IR) in response to adiponectin or insulin stimulation. In addition,
we demonstrate that phosphorylation at Ser401 is critical for
APPL1 to mediate the crosstalk between insulin and adiponec-
tin pathways. Our results uncover a mechanism by which
APPL1 promotes adiponectin signaling and its insulin-sensi-
tizing effect.ell Reports 7, 1227–1238, May 22, 2014 ª2014 The Authors 1227
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Figure 1. Deletion of the appl1 Gene Leads to Insulin Resistance in Mice
(A) Schematic representation of the genomic structure of the appl1 gene. Insertion of the trapping vector (pGTxf) fragment, which contains a splice acceptor (SA),
a b-geo cassette, and a polyadenylation sequence (pA), between exon 7 and exon 8 leads to the disruption of the appl1 gene transcription and expression.
(B) Body weight changes of APPL1 wild-type, heterozygous, and homozygous KO mice were monitored weekly for 24 weeks under normal chow conditions.
(C) Food intake of APPL1 wild-type, heterozygous, and homozygous KO mice was monitored weekly for 24 weeks under normal chow conditions.
(D and E) Fasting serum insulin (D) and glucose (E) levels of wild-type and APPL1 KO mice.
(F and G) Insulin tolerance test (ITT) (F) and glucose tolerance test (GTT) (G).
(H–J) Glucose infusion rates (GIR) (H), total glucose disposal (I), and hepatic glucose production (HGP) suppression (J) during hyperinsulinemic-euglycemic
clamp.
All results are presented as mean ± SEM. p values were calculated using the Student’s t test (*p < 0.05, **p < 0.01, ***p < 0.001). See also Figure S1.RESULTS
APPL1 Promotes Insulin Sensitivity In Vivo
We generated APPL1 KO mice by the gene trap technique (Fig-
ures 1A and S1A–S1C). Consistent with a previous report that
APPL1 is dispensable for mouse development (Tan et al.,
2010b), crossing APPL1 heterozygous mice produced litters
with the expected Mendelian ratios and normal body size.
APPL1 KO mice are viable and fertile and have no significant
differences inbodyweight (Figure1B), food intake (Figure1C), ox-
ygen consumption (Figure S1D), tissue weights (Figure S1E), and
respiratory rates (Figure S1F) compared to wild-type littermates.1228 Cell Reports 7, 1227–1238, May 22, 2014 ª2014 The AuthorsHowever, KO mice were more active (Figure S1G) and had a
higher core body temperature (Figure S1H) and enhanced UCP-
1 expression in their brown fat tissues (Figure S1I) compared to
theirwild-type littermates.KOof theappl1genehadnosignificant
effect on mouse insulin, adiponectin, and leptin levels as well as
lipid profile under fed conditions (Figure S1J). Under fasting con-
ditions, however, both the plasma insulin (Figure 1D) and glucose
(Figure 1E) levels of KO mice were significantly higher than those
of wild-type littermates. APPL1KOmice showed impaired insulin
(Figure 1F) and glucose (Figure 1G) tolerance and significant
reductions in glucose infusion rate (Figure 1H), total glucose
disposal (Figure 1I), and insulin-mediated suppression of hepatic
glucose production (Figure 1J) during the hyperinsulinemic-
euglycemic clamp compared to their wild-type littermates.
These results, collectively, demonstrate that mice lacking
APPL1 manifest insulin resistance.
APPL1 Mediates Insulin and Adiponectin Signaling
In Vivo
To elucidate the mechanisms underlying APPL1-deficiency-
induced insulin resistance, we examined the effect of appl1
gene disruption on insulin signaling in peripheral insulin-respon-
sive tissues. There was no significant difference in basal insulin
signaling in skeletal muscle, liver, and adipose tissues between
APPL1 KO mice and wild-type littermates (Figures 2A, 2B, and
S2A). However, KO mice displayed a marked reduction of insu-
lin-stimulated tyrosine phosphorylation of IRS1/2, phosphoryla-
tion of Akt (Thr308 and Ser473), and phosphorylation of glycogen
synthase kinase 3 b (GSK3b) (Ser9) in skeletal muscle (Figure 2A),
liver (Figure 2B), and adipose tissues (Figure S2A) compared to
wild-type littermates, indicating that APPL1 plays a promoting
role in insulin action in vivo. Interestingly, disruption of the appl1
genehadno effect on insulin-stimulated tyrosinephosphorylation
of insulin receptor subunit b (IRb) in all peripheral insulin target tis-
sues (Figures 2A, 2B, and S2A), suggesting that APPL1 promotes
insulin signalingbyactingonasite downstreamof the IRalong the
phosphatidylinositol 3-kinase (PI3K) signaling pathway.
Because APPL1 plays an important role in adiponectin
signaling (Cheng et al., 2007; Mao et al., 2006), we examined
the effect of appl1 disruption on adiponectin action in vivo. The
administration of adiponectin stimulated AMPK phosphorylation
in skeletal muscle, liver, and adipose tissues of wild-type mice,
and the stimulatory effect of adiponectin was significantly
reduced in KOmice (Figures 2C, 2D, and S2B) but had no signif-
icant effect on Akt phosphorylation in these tissues (Figures 2C,
2D, and S2B), which is consistent with our previous findings that
adiponectin alone is not sufficient to stimulate Akt phosphoryla-
tion in muscle cells (Mao et al., 2006).
APPL1Mediates Insulin Signaling via a Direct Binding to
Insulin Receptor
To elucidate themolecular mechanism underlying APPL1 action,
we examined whether altering APPL1 expression affects
insulin-stimulated phosphorylation of IRb, IRS1, and Akt in
C2C12 myocytes. Overexpression (Figure 3A) or suppression
of APPL1 (Figure 3B) potentiated or impaired, respectively, insu-
lin-stimulated tyrosine phosphorylation of IRS1 and Akt Thr308
phosphorylation in C2C12 myocytes. On the other hand, altering
the expression levels of APPL1 had little effect on the tyrosine
phosphorylation of IRb (Figures 3A and 3B), confirming that
APPL1 promotes insulin signaling at a site downstream of IRb.
Given that APPL1 contains several protein-protein interaction
domains (Figure S3A) and acts as a scaffold protein in adiponec-
tin signaling (Xin et al., 2011), we examined whether APPL1 inter-
acts with insulin-signaling molecules. By in vitro pull-down
studies, we found that glutathione S-transferase (GST) fused to
the C terminus of APPL1 (GST-APPL1CT), but not GST alone or
GST fused to the BAR domain of APPL1 (GST-APPL1BAR), inter-
acted with IRb (Figure 3C). To determine whether APPL1 binds
directly to IRb, we examined the interaction between affinity-Cpurified IRb (Figures S3B and S3C) and GST-APPL1 fusion pro-
teins (Figure S3D). The affinity-purified IRb interacted with the
GST-APPL1 and the GST-APPL1CT fusion proteins, but not
with theGST alone orGST-APPL1BAR fusion proteins (Figure 3D),
indicating that APPL1 physically interacts with IRb directly. In
addition, endogenous IRb was coimmunoprecipitated with
endogenous APPL1 in C2C12 myotubes, and the interaction
was stimulated by insulin (Figure 3E). Of note, insulin treatment
had no effect on the interaction between IRb and APPL1 in the
in vitro pull-down assays (Figure 3C), suggesting that the stimu-
latory effect of insulin may be a result of insulin-stimulated post-
translational modification of APPL1 rather than IR in intact cells.
There are six tyrosine residues on IRb, and phosphorylation at
these sites is essential for IRb to interact with Src homology 2
(SH2) or PTB-domain-containing proteins (White and Kahn,
1994). Because APPL1 contains a PTB domain located at the
C-terminal part of this protein (Figure S3A) and its interaction
with IRb is stimulated by insulin in intact cells (Figure 3E), we
asked whether tyrosine phosphorylation of IRb is essential for
its binding to APPL1. By yeast two-hybrid assays, we found
that mutations of the tyrosine phosphorylation sites of IRb, which
were previously shown to disrupt the interaction between IRb
and the SH2-domain-containing protein Grb10 (Dong et al.,
1997), had no effect on the interaction between APPL1 and IRb
(Figure S3E), suggesting that the interaction between IRb and
APPL1 is independent of IRb tyrosine phosphorylation.
APPL1 shares a high sequence homology with its isoform,
APPL2 (Miaczynska et al., 2004; Wang et al., 2009). However,
APPL1 contains a coil-coiled (CC) region that is absent
in APPL2 (Deepa and Dong, 2009). Because APPL2 does not
interact with IRb (data not shown), we asked whether the CC
region of APPL1 is essential for the interaction between APPL1
and IRb. Coimmunoprecipitation experiments revealed that
deletion of the CC domain disrupted the interaction between
APPL1 and IRb (Figure S3F), demonstrating that the CC domain
is essential for the interaction between APPL1 and IRb.
The Stimulatory Effect of APPL1 on Insulin Signaling
Is IRS Dependent
We investigated whether APPL1 is able to substitute IRS1/2 to
mediate insulin signaling. While we found that overexpression
of APPL1 greatly enhanced insulin-stimulated Akt activation in
mouse embryonic fibroblasts (MEFs) lacking IRS1 (Figure 4A) or
IRS2 (Figure 4B), overexpression of APPL1 had no effect on insu-
lin-stimulated Akt phosphorylation in 32D/IR cells (Figure 4C),
which lack both endogenous IRS1 and IRS2 (Myers et al.,
1996), indicating that the effect of APPL1 on insulin signaling de-
pends upon IRS proteins. Consistent with this, overexpression of
APPL1 enhanced insulin-stimulated Akt phosphorylation in 32D/
IR stably expressing exogenous IRS1 (Myers et al., 1996) (Fig-
ure 4C), and KO of APPL1 had no significant effect on epidermal
growth factor-stimulated phosphorylation of epidermal growth
factor receptor and Akt in vivo (data not shown).
APPL1 Interacts with IRS1/2, and the Interaction
Is Inhibited by Insulin
To further characterize the interaction between APPL1 and IRS
proteins, we performed in vitro binding studies. We found thatell Reports 7, 1227–1238, May 22, 2014 ª2014 The Authors 1229
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Figure 2. Adiponectin and Insulin Signaling Are Impaired in APPL1 KO Mice
(A and B) Fasted wild-type and APPL1 KOmice were injected intraperitoneally (i.p.) with insulin (0.5 U/kg of body weight) for 3 min. Insulin signaling was detected
in skeletal muscle (A) and liver tissues (B) by western blot analysis.
(C and D) Overnight-fasted wild-type and APPL1 KO mice were refed for 4 hr and then injected (i.p.) with adiponectin (Ad) (5 mg/g of body weight) for 1 hr.
Adiponectin and insulin signaling were detected in skeletal muscle (C) and liver tissue (D) by western blot analysis.
All results are presented as mean ± SEM. p values were calculated using the Student’s t test (*p < 0.05, **p < 0.01). See also Figure S2.
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Figure 3. APPL1 Interacts with IRb
(A) C2C12 myoblasts overexpressing Myc-tagged APPL1 were serum-starved and treated with or without 100 nM insulin for 3 min. Phosphorylation of IRS1, IRb,
and Akt and protein levels were detected with specific antibodies as indicated.
(B) Scrambled control and APPL1 suppressedC2C12myotubes were serum-starved and treated with or without 10 nM insulin for 3min. Phosphorylation of IRS1,
IRb, and Akt were detected with specific antibodies as indicated.
(C) Glutathione agarose beads linked with GST, GST-APPL1, APPL1CT, or APPL1BAR fusion proteins were incubated with cell lysates of C2C12myotubes treated
with or without 10 nM insulin for 5 min. Endogenous IRb associated with GST-APPL1 or GST-APPL1 truncations was detected with antibodies specific for IRb.
(D) The purified IR was incubated with GST or GST-APPL1 fusion proteins bound to glutathione agarose beads at 4C overnight. APPL1-associated IRb was
detected by western blot analysis.
(E) Serum-starved C2C12myotubes were treated with or without 10 nM insulin (3 min). Endogenous APPL1was immunoprecipitated, and coimmunoprecipitated
endogenous IRbwas detected by western blot analysis. Data are shown asmean ±SEM from three independent experiments. p values were calculated using the
Student’s t test (*p < 0.05).
See also Figure S3.the GST-APPL1, but not GST, interacted with IRS1 (Figure 5A). A
truncation mapping study indicated that multiple domains of
APPL1 (the BAR, PH, and PTB) are involved in the interaction
of APPL1 with IRS1 (data not shown). Coimmunoprecipitation
studies revealed that endogenous IRS1 interacted with endoge-
nous APPL1 in C2C12 myotubes under the basal condition (Fig-
ure 5B). Interestingly, the interaction between APPL1 and IRS1 is
inhibited by insulin stimulation (Figure 5B), which is opposite to
the interaction between APPL1 and IRb that is stimulated by
insulin (Figure 3E).
The Binding of APPL1 to IRb Is Necessary for the
Stimulatory Effect of APPL1 on Insulin-Stimulated
IRb-IRS1/2 Interactions and Signaling
We investigated whether APPL1 promotes insulin signaling by
facilitating the recruitment of IRS1 onto IRb, which is a critical
step for the transduction of insulin signaling to downstream tar-
gets (Taniguchi et al., 2006). We found that overexpression of
APPL1 greatly enhanced the insulin-stimulated IRS1 interaction
with IRb in C2C12 cells (Figure 5C). On the other hand, suppres-Csion of APPL1 expression markedly reduced the effect of insulin
on the interaction (Figure 5D). Together, these data suggest that
APPL1 may exert its insulin-sensitization function by promoting
IRS1’s interaction with IRb. To determine whether the binding
to IRb is necessary for the stimulatory effect of APPL1, we exam-
ined the effect of APPL1DCC, which is unable to interact with IRb
(Figure S3F), on insulin signaling. Overexpression of APPL1DCC
had no stimulatory effect on the interaction of insulin-stimulated
IRS1 with IRb and Akt phosphorylation (Figure 5C), indicating
that the binding of APPL1 to IRb is essential for the insulin-sensi-
tizing effect of APPL1.
APPL1 Coordinates the Interaction of IRb with IRS1
To determine if the APPL1/IR/IRS1 complex is dynamically regu-
lated by insulin, we examined the kinetics of insulin-induced
APPL1/IRS1 dissociation and IRS1/IRb interaction. Insulin stim-
ulation led to a time-dependent dissociation between APPL1
and IRS1 concurrently with a time-dependent increase in IRS1
tyrosine phosphorylation and the interaction between IRb and
IRS1 (Figure 5E). Together, these results suggest that APPL1ell Reports 7, 1227–1238, May 22, 2014 ª2014 The Authors 1231
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Figure 4. APPL1 Mediates Insulin Signaling in an IRS1/2-Dependent
Manner
MEF cells derived from IRS1 KO mice (A), IRS2 KO mice (B), or 32D/IR and
32D/IR/IRS-1 cells (C) were infected by adenovirus overexpressing GFP or
GFP plus APPL1. The infected cells were serum starved for 4 hr and treated
with or without 100 nM insulin (5 min). Akt phosphorylation and protein
expression levels were detected with specific antibodies as indicated.may function as a carrier to bring IRS1 to IRb in response to
insulin stimulation.
APPL1 Ser401 Phosphorylation Correlates with Insulin
Sensitivity
APPL1 contains several potential phosphorylation sites
including Ser151, Ser401, Ser427, and Ser430 (Gant-Branum
et al., 2010) that may be subjected to insulin- or adiponectin-
stimulated phosphorylation. Among these potential phosphory-
lation sites, Ser401 is highly conserved in APPL1 among different
species, and this residue is absent in the corresponding location
of its isoformAPPL2 (Figure S4A); the latter does not interact with
the IR (data not shown). To determine the potential roles of
APPL1 phosphorylation, we generated a phosphospecific anti-
body to Ser401 of APPL1 (Figure S4B). By western blot analysis
using this antibody, we found that APPL1 phosphorylation at
Ser401 is rapidly stimulated by insulin in C2C12 cells (Figure 6A)
and in mouse skeletal muscle tissues (Figure 6B). The insulin-
stimulated APPL1 Ser401 phosphorylation was significantly
reduced in insulin target tissues of mice fed a high-fat diet
compared to mice fed with normal chow, which was associated
with an impaired PI3K signaling pathway (Figures 6C, S4C, and
S4D). Together, these results indicate a correlation between
APPL1 phosphorylation at Ser401 and insulin sensitivity in vivo.1232 Cell Reports 7, 1227–1238, May 22, 2014 ª2014 The AuthorsSer401 Phosphorylation Regulates APPL1 Binding to IRb
and Dissociation with IRS1
To investigate the role of Ser401 phosphorylation in mediating the
insulin-sensitizing role of APPL1, we overexpressed RNAi-resis-
tant wild-type and phosphorylation mutants (S401A and S401D)
of APPL1 in APPL1-suppressedC2C12 cells. Consistent with the
notion that the binding of APPL1 to IRb sensitizes insulin
signaling by acting at a site downstream of the IR (Figures 2A,
2B, and S2A), overexpression of either APPL1S401A or
APPL1S401D had no effect on insulin-stimulated IRb tyrosine
phosphorylation (Figure 6D). However, replacing Ser401 with
alanine greatly impaired the ability of APPL1 to bind with IRb in
response to insulin stimulation, concurrent with a loss of
response to insulin-stimulated dissociation from IRS1 and IRS2
(Figure 6D). Consequently, the promoting effect of APPL1 on
insulin-stimulated tyrosine phosphorylation of IRS1/2, phos-
phorylation of Akt at both Thr308 and Ser473, and GSK3b activa-
tion was significantly reduced by mutating serine401 of APPL1 to
alanine (Figure 6D). Conversely, the S401D mutant of APPL1
showed high binding affinity to IRb, which occurs concurrently
with a reduced interaction with IRS proteins and enhanced insu-
lin signaling compared to wild-type APPL1 (Figure 6D). Taken
together, these results clearly demonstrate that phosphorylation
at Ser401 plays a key role in mediating the insulin-regulated bind-
ing of APPL1 with IRb and dissociation with IRS proteins.
APPL1 has previously been shown to bind to inactive Akt (Mit-
suuchi et al., 1999). Consistent with this finding, we found that
APPL1 interacted with Akt under basal conditions (Figure 6D).
Like IRS1/2, Akt dissociates from the APPL1-IRb complex in
response to insulin stimulation (Figure 6D). These results suggest
that in addition to facilitating IRS1/2’s interaction with the IR,
APPL1 also promotes Akt translocation to the plasmamembrane
for insulin-stimulated activation. Interestingly, neither S401A nor
S401Dmutant hadanyeffectonAPPL1/Akt interactioncompared
with wild-type protein (Figure 6D), suggesting that phosphoryla-
tion at Ser401 is not essential for regulating APPL1/Akt binding.
Adiponectin Promotes Ser401 Phosphorylation
and APPL1-IRb Interaction
To determine whether adiponectin has an effect on APPL1 phos-
phorylation and interaction with IRb, we treated C2C12 cells with
adiponectin alone or together with insulin. Adiponectin treat-
ment greatly stimulated APPL1 phosphorylation at Ser401 and
enhanced APPL1 interaction with IRb (Figures 7A and S5A). No
synergistic effect of adiponectin and insulin on APPL1 phosphor-
ylation and its binding to IRbwas observed (Figure 7A), suggest-
ing that a common mechanism may be used by insulin and
adiponectin to induce APPL1 phosphorylation. In agreement
with this view, treating C2C12 cells with the protein kinase C
(PKC) inhibitor Go¨6983, but not inhibitors for GSK3b (LiCl),
mitogen-activated protein kinase kinase (PD98059), or PI3K
(LY-294002), blocked both insulin- and adiponectin-induced
Ser401 phosphorylation (Figures S5B and S5C). Taken together
with the findings that phorbol ester phorbol-12-myristate-13-
acetate stimulated the phosphorylation (Figure S5D) and that
the insulin- and adiponectin-stimulated phosphorylation was
inhibited by Go¨6976 (Figure S5E), a selective inhibitor of
Ca2+-dependent PKC isoforms such as PKCa and PKCbI, it is
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Figure 5. APPL1 Facilitates the Recruitment of IRS1 onto IRb
(A) Glutathione agarose beads containing GST, GST-APPL1 fusion proteins were incubated with lysates of C2C12myotubes treated with or without 10 nM insulin
(3 min). Endogenous IRS1 associated with GST-APPL1 fusion proteins was detected with an antibody specific to IRS1.
(B) Serum-starved C2C12 myotubes were treated with or without 10 nM insulin (3 min). Endogenous APPL1 was immunoprecipitated with an antibody to APPL1,
and the coimmunoprecipitated IRS1 was detected by western blot analysis using an antibody to IRS1. Data are shown as mean ± SEM from three independent
experiments. p values were calculated using the Student’s t test (*p < 0.05).
(C) C2C12 myocytes transfected with or without myc-tagged APPL1 or APPL1DCC truncation were serum-starved and treated with or without 100 nM insulin
(3min). Endogenous IRbwas immunoprecipitated, and coimmunoprecipitated endogenous IRS1 or myc-tagged APPL1was detected with specific antibodies as
indicated.
(D) Scrambled control and APPL1-suppressed C2C12 myotubes were serum-starved and treated with or without 10 nM insulin (3 min). Endogenous IRb was
immunoprecipitated, and coimmunoprecipitated IRS1 was detected by western blot analysis with the antibodies as indicated.
(E) Serum-starved C2C12 myotubes were treated with or without 10 nM insulin for the indicated times. Endogenous IRS1 was immunoprecipitated, and
coimmunoprecipitated endogenous IRb and APPL1 were detected by western blot analysis with the antibodies as indicated.conceivable that a conventional PKC isoform may mediate
both insulin- and adiponectin-stimulated APPL1 phosphoryla-
tion at Ser401.
To investigate the role of adiponectin-stimulated APPL1 phos-
phorylation in regulating APPL1/IRb interaction, we overex-
pressed RNAi-resistant wild-type and phosphorylation mutants
(S401AandS401D) of APPL1 inAPPL1-suppressedC2C12cells.
Replacing Ser401 with alanine greatly impaired adiponectin-
stimulated APPL1 binding with IRb (Figure 7B). Conversely, the
S401D mutant of APPL1 displayed an enhanced ability to bind
with IRb (Figure 7B). Taken together, these results indicate that
phosphorylation at Ser401 provides a key mechanism by which
adiponectin regulates the binding of APPL1 with IRb and IRS1/2.
While insulin treatment triggered the dissociation between
APPL1 and IRS1/2 (Figures 6D and 7A), we found that adiponec-
tin had no effect on APPL1/IRS1 dissociation (Figure 7A). Time
course studies also revealed that adiponectin treatment did
not affect the interaction between IRS1 and APPL1 or IRb (Fig-Cure S5F). These results are consistent with our previous finding
that adiponectin by itself does not stimulate Akt phosphorylation
in cells (Mao et al., 2006). In agreement with these results,
adiponectin treatment alone did not stimulate the tyrosine
phosphorylation of IRb and IRS1 or the serine/threonine phos-
phorylation of Akt and GSK3b (Figure 7A).
DISCUSSION
In this study, we demonstrate that APPL1 interacts with both IRb
and IRS1/2 and acts as an adaptor protein to facilitate the insu-
lin-stimulated recruitment of IRS1/2 onto IRb (Figure 7C). Under
basal conditions, APPL1 forms a complex with IRS1/2 and Akt in
the cytosol. The insulin- or adiponectin-induced APPL1 Ser401
phosphorylation promotes APPL1 binding directly to the IR,
allowing APPL1 to piggyback IRS proteins onto the IR. Insulin
stimulation further induces the dissociation of IRS proteins and
Akt from the APPL1-IR complex, facilitating the binding ofell Reports 7, 1227–1238, May 22, 2014 ª2014 The Authors 1233
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Figure 6. Ser401 Phosphorylation Is Essential for the Promoting Effect of APPL1 on Insulin Signaling
(A) C2C12 myotubes were serum-starved and treated with insulin (10 nM) for the indicated times. Phosphorylation of APPL1 and Akt were detected by western
blot analysis with the specific antibodies indicated.
(B) C57BL/6 mice were fasted and injected with saline or insulin (0.5 U/kg of body weight, 3 min). The phosphorylation of APPL1 and Akt and their protein
expression in muscle tissues were detected by western blot analysis. n = 9 per group.
(C) Normal chow (NC) and high-fat diet (HFD)-fed male C57BL/6 mice were fasted overnight and treated with or without insulin (0.5 U/kg of body weight, 3 min).
The phosphorylation of APPL1 and APPL1 protein in muscle tissues was detected by western blot analysis. Phosphorylation of IRb, IRS1, and IRS2 was detected
after immunoprecipitation with indicated antibodies, respectively. Bar graphs represent the ratios of insulin-stimulated phosphorylation over their total protein
levels. n = 4 per group.
(D) APPL1-suppressed C2C12 myoblasts were transfected with myc-tagged and RNAi-resistant wild-type (WT), S401A, or S401D mutants of APPL1. The cells
were serum-starved and treated with or without 100 nM insulin (3 min). WT and mutants of APPL1 were immunoprecipitated with an anti-myc antibody. Bar
graphs represent the binding of IRb, IRS1, or IRS2 to APPL1 protein. Data are mean ± SEM from three independent experiments.
All results are presented as mean ± SEM. p values were calculated using the Student’s t test (*p < 0.05, **p < 0.01, ***p < 0.001). See also Figure S4.
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Figure 7. Adiponectin Stimulates the Interac-
tion between APPL1 and IRS1
(A) Serum-starved C2C12 myotubes were pre-
treated with or without adiponectin (1 mg/ml, 10 min)
and then with or without insulin (10 nM, 3 min).
Endogenous APPL1 was immunoprecipitated.
Coimmunoprecipitated IRb or IRS1 and phosphor-
ylated IR, IRS1, Akt, GSK3b, or APPL1 and their
protein levels in cell lysates were detected by
western blot analysis with specific antibodies as
indicated.
(B) APPL1-suppressed C2C12 myocytes were
transfected with myc-tagged and RNAi-resistant
WT, S401A, or the S401D mutant form of APPL1.
Transfected cells were serum-starved and treated
with adiponectin (1 mg/ml, 10 min). WT and mutant
APPL1 were immunoprecipitated with an anti-myc
antibody. Coimmunoprecipitated IRb, IRS1, or IRS2
and their protein levels and phosphorylated APPL1
in the cell lysates were determined by western blot
analysis using specific antibodies to these proteins.
(C) The model of the sensitization role of APPL1 in
insulin signaling.
See also Figure S5.IRS1/2 to the activated IR near the plasmamembrane. Our study
thus reveals a mechanism underlying the role of APPL1 in sensi-
tizing the insulin-stimulated PI3K pathway.
APPL1 has previously been shown to be phosphorylated at
Ser401 in human skeletal muscle (Holmes et al., 2011). However,
the role of this phosphorylation is unknown.We found that Ser401
phosphorylation is significantly impaired in skeletal muscle, liver,
and adipose tissues of mice fed a high-fat diet, suggesting that
impairment of this phosphorylation may have a pathophysiolog-
ical role in metabolism. Consistent with this view, Ser401 phos-
phorylation plays a key role in regulating the interaction between
APPL1 and IRb or IRS1/2. Residue Ser401 is located in a region
between the PH domain and the C terminus of APPL1. Of note,
the C-terminal part of APPL1 is essential for the interaction of
APPL1 with its multiple binding partners, including AdipoR1,
DCC, and follicle-stimulating hormone receptor. Interestingly,
all of these interactions appear to be independent of the tyrosineCell Reports 7, 1227–12phosphorylation of the receptors (Liu et al.,
2002; Mao et al., 2006; Nechamen et al.,
2004). Our current study shows that
APPL1 binds to wild-type and tyrosine
phosphorylation site mutants of IRb to a
similar extent in the yeast two-hybrid sys-
tem. In addition, the pull-down study
reveals that APPL1 binds with a similar
affinity to IRb expressed in C2C12 myo-
tubes treated with or without insulin. These
data suggest that the regulation of APPL1/
IR interaction is via postmodification of
APPL1 rather than tyrosine phosphoryla-
tion of IR. It is interesting to note that
APPL2, which does not contain Ser401,
did not interact with IRb in cells (data not
shown). Because IR binds to the CC regionof APPL1, phosphorylation at Ser401 could induce a conforma-
tional change, which makes the C-terminal region more acces-
sible for the interaction with the receptor. Further studies on
the structure of the APPL1 Ser401 mutant or the complex
between the CC region of APPL1 and its binding partners may
shed light on the molecular mechanism regulating this type of
interaction.
Adiponectin promotes APPL1 Ser401 phosphorylation but
does not stimulate insulin signaling in C2C12 cells or in vivo,
demonstrating that this phosphorylation alone is not sufficient
to activate IR downstream signaling events. One possible expla-
nation is that while phosphorylated APPL1 is able to deliver IRS1/
2 onto the IRb, the tyrosine phosphorylation of IRS proteins and
the activation of downstream signaling events depend on the
kinase activation of IRb, which is stimulated by insulin. Consis-
tent with this view, adiponectin treatment alone has no stimula-
tory effect on the insulin-stimulated activation of IRS1 and Akt in38, May 22, 2014 ª2014 The Authors 1235
cells from muscle, liver, and heart (Fang et al., 2010; Mao et al.,
2006; Wang et al., 2007a; Yamauchi et al., 2001). These results
reveal distinctive roles of adiponectin and insulin in regulating
the interaction between IRS1/2 and APPL1 and provide a mech-
anism by which adiponectin sensitizes insulin signaling.
In addition to the IR and IRS1/2, APPL1 has previously been
shown to interact with other components of the insulin-signaling
pathway, including the p110 subunit of PI3K and Akt (Mitsuuchi
et al., 1999). The interaction between APPL1 and Akt has been
shown to prevent Akt from binding to its inhibitor, TRB3, thus
promoting the membrane translocation of Akt (Cheng et al.,
2009). Interestingly, insulin has been found to cause the dissoci-
ation of APPL1 from Akt (Mitsuuchi et al., 1999; Saito et al.,
2007). Our study indicated that both insulin and adiponectin
could induce dissociation of the APPL1-Akt complex. However,
the binding of APPL1 with Akt is independent of Ser401 phos-
phorylation, suggesting that APPL1 interacts with Akt or IRS1/
2 via distinct mechanisms. It is currently unknown whether
APPL1 functions as a carrier to facilitate the interaction between
Akt and its binding partners/substrates. Nevertheless, these
findings imply that APPL1 may promote insulin signaling by
orchestrating the essential protein-protein interactions in the
signaling pathway, thus controlling the efficiency and specificity
of the insulin-signaling transduction.
APPL1 is located in the nucleus, endosome, and cytosol in
various cells (Miaczynska et al., 2004; Saito et al., 2007). The
APPL1-positive endosomes, which reside at the cell edge (Zoncu
et al., 2009), have been suggested to be involved in cargo traf-
ficking (Urbanska et al., 2011) and Akt substrate selection
(Schenck et al., 2008). Because the IR and its downstreammole-
cules, including IRS1, are found in endosomes (Kublaoui et al.,
1995;Wang et al., 1996), it is possible that the APPL1-associated
endosomes play a role in regulating insulin signaling. We previ-
ously found that APPL1 selectively promotes the PI3K/Akt, but
not the ERK1/2, singling pathway in C2C12 cells (Mao et al.,
2006). In addition, APPL1 interacts with IRS1/2 in the cytosol,
and the interaction is regulatedbyAPPL1Ser401 phosphorylation.
Interestingly, this phosphorylation has no effect on the interaction
between APPL1 and Akt, which has been shown to occur in the
endosome (Schenck et al., 2008). Thus, there seem to be distinct
cytosolic and endosomal pools of APPL1 thatmay play important
roles in regulating the substrate selectivity and signaling speci-
ficity in cells. One possible model is that cytosolic APPL1 carries
IRS1/2 onto IR on the cell surface, facilitating insulin-stimulated
IR-IRS1/2 interaction. APPL1-positive endosomes, however,
may contribute to IRS1/2 endocytosis after rapid activation by
plasma membrane IR. Because internalized IR is highly active
(Wang et al., 1996), APPL1-positive endosomes may bring acti-
vated IRS proteins in close proximity to the intercellular IR to
further sensitize insulin signaling. Consistent with this view,
internal-membrane-associated IRS1 has been found to undergo
insulin-stimulated tyrosine phosphorylation (Kublaoui et al.,
1995). It is possible that adiponectin sensitizes insulin signaling
by promoting IRS1 endocytosis via APPL1-positive endosomes,
thus providing a synergistic effect on insulin-stimulated down-
stream events. Further studies are needed to test this possibility.
Our results show that KO of the appl1 gene in mice reduced
insulin sensitivity and impaired insulin and adiponectin signaling1236 Cell Reports 7, 1227–1238, May 22, 2014 ª2014 The Authorsin vivo. While these results are in agreement with the finding that
APPL1 is essential for insulin action in mouse adipose and liver
tissue (Cheng et al., 2009; Saito et al., 2007), it should be noted
that some studies showed that disruption of the appl1 gene in
mice had no significant effect on insulin sensitivity (Tan et al.,
2010a, 2010b). The reason for the discrepancy between our re-
sults and those of Tan et al. remains unknown but could be
related to the differences in the KO animal models used (gene
trapping versus exon 1 or 5 KO), tissues investigated (liver, skel-
etal muscle, and adipose tissue versus brain, lung, and thymic
T cells), and approaches used to detect the effect of APPL1 on
insulin signaling (insulin-stimulated versus basal Akt phosphory-
lation). To the last point, it is interesting to note that in the study
by Tan et al. (Tan et al., 2010a), Akt phosphorylation in brain,
lung, and thymic T cells was measured under basal conditions.
In a subsequent study (Tan et al., 2010b), the effect of APPL1
on insulin-stimulated Akt phosphorylation was measured only
in MEFs and not in APPL1 KO mice. On the other hand, we
have demonstrated that disruption in appl1 gene expression in
mice had a marked effect not only on insulin-stimulated serine/
threonine phosphorylation of Akt and GSK3b but also on insu-
lin-stimulated tyrosine phosphorylation of IRS1/2 in different
insulin target tissues such as liver, skeletal muscle, and adipose
tissue. These results are consistent with our findings and those
of others showing that APPL1 plays an important role in regu-
lating in vivo insulin signaling and action in various animal models
(Cheng et al., 2009; Cleasby et al., 2011; Schenck et al., 2008;
Wang et al., 2011, 2013; Wen et al., 2010).
The mechanisms underlying the insulin-sensitizing effects of
adiponectin remain to be fully elucidated. Our results demon-
strate that APPL1 potentiates the effect of insulin on IRS1/2,
but not IRb, tyrosine phosphorylation in cells and in vivo, which
is consistent with our previous finding that adiponectin, by
suppressing the negative effect of S6K on IRS1, promotes insu-
lin-stimulated tyrosine phosphorylation of IRS1, but not the IR
(Wang et al., 2007a). Together, these results indicate a direct
crosstalk between the adiponectin- and insulin-signaling path-
ways. Under the in vivo condition, however, adiponectin may
sensitize insulin signaling via both direct and indirect mecha-
nisms. Consistent with this view, adiponectin has been shown
to reduce the levels of triglycerol and diglycerol and increase
insulin secretion in vivo (Holland et al., 2011; Kim et al., 2007;
Yamauchi et al., 2001), which may lead to enhanced tyrosine
phosphorylation of the IR.
In summary, our study has identified APPL1 as a binding part-
ner of IR and IRS proteins. We have also demonstrated that
APPL1 phosphorylation at Ser401, which is downregulated in
obesity, plays a key role in regulating the interaction between
APPL1 and the IR or IRS1/2 and thus insulin signaling. The
finding that Ser401 phosphorylation is stimulated by adiponectin
also uncovers a mechanism underlying the crosstalk between
the adiponectin- and insulin-signaling pathways.EXPERIMENTAL PROCEDURES
Plasmids, Adiponectin, and Antibodies
The cDNAs of full-length and truncations of human APPL1 were generated as
described previously (Wang et al., 2009). RNAi-resistant APPL1 construct was
generated by mutating the codon for Cys368 from TgT to Tgc by PCR and
cloned into pcDNA vector. The recombinant globular adiponectin and anti-
body specific to APPL1 were generated in our lab (Mao et al., 2006; Wang
et al., 2009). All other antibodies were obtained from Cell Signaling Technolo-
gies. The phosphospecific antibody against APPL1 Ser401 was homemade
(Figure S4B). The pan phosphotyrosine antibody (4G10) against tyrosine phos-
phorylation of IRb and IRS1/2 proteins was purchased from Millipore.
Generation of APPL1 Knockout Mice
The APPL1-deficient mouse embryonic stem cell (ESC) line, in which the appl1
gene was trapped by the insertion of a cDNA fragment encoding b-geo (con-
taining b-galactosidase and neomycin gene) and a polyadenylation signal
between exons 7 and 8, was obtained from Bay Genomics (cell line no.
RRS819). To generate APPL1 KO mice, the APPL1 gene-trapped ESCs were
microinjected into C57BL/6 blastocysts and chimeras were crossed with
C57/BL6 mice. Animals were maintained on a 12 hr light/dark cycle and had
free access to standard normal chow and water. All protocols for animal use
and euthanasia were reviewed and approved by the University of Texas Health
Science Center Animal Care and Use Committee.
Animal Studies
Male mice were used in this study. For the glucose-tolerance test, mice were
starved for 16 hr and then injected intraperitoneally with glucose (2 g/kg). Tail
vein blood glucose was checked using an automatic glucometer (Rightest
GM300; Bionime) at the indicated time. For the insulin-tolerance test, 4-hr-
fasted mice were injected intraperitoneally with 0.75 U/kg insulin (Humulin R,
Eli Lilly) and tail vein blood glucose was then measured at the indicated
time. For the in vivo insulin-stimulation assay, male mice 10 to 12 weeks of
age were fasted overnight and injected intraperitoneally with insulin
(0.5 U/kg of body weight) or an equal volume of saline. After 3 min, the mice
were sacrificed via cervical dislocation. For the high-fat diet treatment,
4-week-old wild-type C57/BL6 mice were fed a high-fat diet (45 kcal% from
fat; ResearchDiets) for 12weeks. Hyperinsulinemic-euglycemic clamp studies
were performed on animals fed with regular chow at 10 weeks of age (n = 7
[wild-type], n = 8 [KO]) as described previously (Wang et al., 2007b). Plasma
concentrations of metabolic factors were measured with the Insulin (Mouse)
Ultrasensitive EIA (ALPCO Diagnostics), Triglyceride Assay Kit (Cayman
Chemical Company), Cholesterol Assay Kit (Cayman Chemical Company),
Free fatty Acid Quantification Kit (Biovision) and NEFA-HR(2) (Wako), Adipo-
nectin (Mouse) ELA (ALPCO Diagnostics), HDL and LDL/VLDL Cholesterol
Quantification Kit (Biovision), and Leptin (mouse) ElA Kit (Assay Designs).
Statistical Analysis
All results are presented as mean ± SEM, and p values were calculated using
the Student’s t test (*p < 0.05, **p < 0.01, and ***p < 0.001).
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and can be found with this
article online at http://dx.doi.org/10.1016/j.celrep.2014.04.006.
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